OTC Healthcare in India
Euromonitor International's OTC Healthcare in India market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Get immediate access to strategic market analysis when you buy reports online
Tables: 107 | Publication date: Feb 2008
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
Adult mouthcare; Allergy care; Analgesics; Calming and sleeping products; Child-specific OTC healthcare; Cough; cold and allergy (hay fever) remedies; Digestive remedies; Ear care; Emergency contraception; Eye care; Medicated skin care; NRT Smoking cessation aids; OTC obesity; OTC statins; OTC triptans; Vitamins and dietary supplements; Wound treatments
Executive summary
Economic growth spurs sales
The growth of OTC products was fairly good in 2006. Growth was supported by continuing economic development in the country, with increasing levels of affluence and consumer sophistication. However, growth was hindered by continuing low-income levels for much of the population, particularly in rural areas, and by a poorly-developed retail infrastructure, in addition to strong competition from UTC sales of Rx medication.
Eye care boosted by growing computer usage
Increasing urbanisation and a growing economy resulted in consumers becoming increasingly focused on their careers, with a surge in office and call centre work. Many consumers are working long hours and this, along with growing pollution, resulted in a higher incidence of eye strain. Consequently, eye care saw the strongest growth in 2006 over the previous year, with growth also exaggerated by a low sales base.
Fragmented shares led by multinationals
GlaxoSmithKline continued to be the leading player in 2006, due to offering a wide range and enjoying a strong reputation for quality, supported by an extensive advertising budget. Amway meanwhile ranked second, despite being only present in vitamins and dietary supplements, due to its high prices and the effectiveness of its direct sales methods. However, domestic player Dabur began to gain share in third place in 2006. The company benefits from a strong ayurvedic tradition and stepped up its advertising and new product development in 2006 in order to regain lost share.
Distribution remains fairly limited
Distribution continues to be dominated by chemists/pharmacies, with drugstores/parapharmacies being the second largest distribution channel. Grocery outlets gained share during the review period but at a slow rate, with the poor distribution infrastructure in the country limiting this channel’s expansion. Many consumers remain uncertain about self-medication and prefer to seek advice from a pharmacist. In addition, in rural areas often only chemists/pharmacies or drugstores/parapharmacies are available as a source of OTC healthcare.
Steady growth expected for forecast period
The forecast period is expected to see a slightly stronger constant value growth for OTC healthcare than seen during the review period. Growth will be underpinned by rising income levels. In addition, higher stress levels, longer working hours, rising pollution and the growth of consumer foodservice will result in greater demand for OTC healthcare, with consumers suffering an increased incidence of allergies, eyestrain, tension headaches, digestive upsets and a host of other problems. Growth will also be supported by players continuing to expand their presence in rural areas.
Table of contents
OTC HEALTHCARE IN INDIA : MARKET INSIGHT
EXECUTIVE SUMMARY
Economic growth spurs sales
Eye care boosted by growing computer usage
Fragmented shares led by multinationals
Distribution remains fairly limited
Steady growth expected for forecast period
KEY TRENDS AND DEVELOPMENTS
Introduction of Schedule K amendments promise good growth
Retailers play an important role in dispensing drugs
Switch to herbal products from standard
Urbanisation and busier lifestyles boost sales
Economic growth makes healthcare more affordable
TERRITORY KEY TRENDS AND DEVELOPMENTS
East and Northeast India
North India
South India
West India
RURAL VS URBAN KEY TRENDS AND DEVELOPMENTS
MARKET INDICATORS
Table 1 Life Expectancy at Birth 2001-2006
MARKET DATA
Table 2 Sales of OTC Healthcare by Sector: Value 2001-2006
Table 3 Sales of OTC Healthcare by Sector: % Value Growth 2001-2006
Table 4 Sales of OTC Healthcare by Region: Value 2001-2006
Table 5 Sales of OTC Healthcare by Region: % Value Growth 2001-2006
Table 6 Sales of OTC Healthcare by Rural-Urban % Value Analysis 2006
Table 7 OTC Healthcare Company Shares by Retail Value 2002-2006
Table 8 OTC Healthcare Brand Shares by Retail Value 2003-2006
Table 9 Sales of OTC Healthcare by Distribution Format: % Analysis 2001/2006
Table 10 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2006
Table 11 Forecast Sales of OTC Healthcare by Sector: Value 2006-2011
Table 12 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2006-2011
Table 13 Forecast Sales of OTC Healthcare by Region: Value 2006-2011
Table 14 Forecast Sales of OTC Healthcare by Region: % Value Growth 2006-2011
APPENDIX
OTC Registration and Classification
Vitamins and dietary supplements registration and classification
Generics
Consumer expenditure on health goods and medical services
Table 15 Consumer Expenditure on Health Goods and Medical Services 2001-2006
DEFINITIONS
Sources
Summary 1 Research Sources
LOCAL COMPANY PROFILES - INDIA
AMRUTANJAN LTD - OTC HEALTHCARE - INDIA
STRATEGIC DIRECTION
KEY FACTS
Summary 2 Amrutanjan Ltd: Key Facts
Summary 3 Amrutanjan Ltd: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 4 Amrutanjan Ltd: Production Statistics 2005-2006
COMPETITIVE POSITIONING
Summary 5 Amrutanjan Ltd: Competitive Position 2006
AMWAY INDIA ENTERPRISES - OTC HEALTHCARE - INDIA
STRATEGIC DIRECTION
KEY FACTS
Summary 6 Amway India Enterprises: Key Facts
Summary 7 Amway India Enterprises: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 8 Amway India Enterprises: Competitive Position 2006
DABUR INDIA LTD - OTC HEALTHCARE - INDIA
STRATEGIC DIRECTION
KEY FACTS
Summary 9 Dabur India Ltd: Key Facts
Summary 10 Dabur India Ltd: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 11 Dabur India Ltd: Production Statistics 2006
COMPETITIVE POSITIONING
Summary 12 Dabur India Ltd: Competitive Position 2006
EMAMI LTD - OTC HEALTHCARE - INDIA
STRATEGIC DIRECTION
KEY FACTS
Summary 13 Emami Ltd: Key Facts
Summary 14 Emami Ltd: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 15 Emami Ltd: Production Statistics 2006
COMPETITIVE POSITIONING
Summary 16 Emami Ltd: Competitive Position 2006
GLAXOSMITHKLINE PHARMACEUTICALS (INDIA) LTD - OTC HEALTHCARE - INDIA
STRATEGIC DIRECTION
KEY FACTS
Summary 17 GlaxoSmithKline Pharmaceuticals Ltd: Key Facts
Summary 18 GlaxoSmithKline Pharmaceuticals Ltd: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 19 GlaxoSmithKline Pharmaceuticals Ltd: Production Statistics 2005
COMPETITIVE POSITIONING
Summary 20 GlaxoSmithKline Pharmaceuticals Ltd: Competitive Position 2006
NICHOLAS PIRAMAL INDIA LTD - OTC HEALTHCARE - INDIA
STRATEGIC DIRECTION
KEY FACTS
Summary 21 Nicholas Piramal India Ltd: Key Facts
Summary 22 Nicholas Piramal India Ltd: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 23 Nicholas Piramal India Ltd: Production Statistics 2006
COMPETITIVE POSITIONING
Summary 24 Nicholas Piramal India Ltd: Competitive Position 2006
PARAS PHARMACEUTICALS LTD - OTC HEALTHCARE - INDIA
STRATEGIC DIRECTION
KEY FACTS
Summary 25 Paras Pharmaceuticals Ltd: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 26 Paras Pharmaceuticals Ltd: Competitive Position 2006
PFIZER LTD - OTC HEALTHCARE - INDIA
STRATEGIC DIRECTION
KEY FACTS
Summary 27 Pfizer Ltd: Key Facts
Summary 28 Pfizer Ltd: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 29 Pfizer Ltd: Production Statistics 2005
COMPETITIVE POSITIONING
Summary 30 Pfizer Ltd: Competitive Position 2006
RANBAXY LABORATORIES LTD - OTC HEALTHCARE - INDIA
STRATEGIC DIRECTION
KEY FACTS
Summary 31 Ranbaxy Laboratories Ltd: Key Facts
Summary 32 Ranbaxy Laboratories Ltd: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 33 Ranbaxy Laboratories Ltd: Production Statistics 2005
COMPETITIVE POSITIONING
Summary 34 Ranbaxy Laboratories Ltd: Competitive Position 2006
ANALGESICS IN INDIA
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 16 Sales of Analgesics by Subsector: Value 2001-2006
Table 17 Sales of Analgesics by Subsector: % Value Growth 2001-2006
Table 18 Herbal vs Standard Topical Analgesics 2001/2006
Table 19 Analgesics Company Shares by Retail Value 2002-2006
Table 20 Analgesics Brand Shares by Retail Value 2003-2006
Table 21 Forecast Sales of Analgesics by Subsector: Value 2006-2011
Table 22 Forecast Sales of Analgesics by Subsector: % Value Growth 2006-2011
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN INDIA
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 23 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2001-2006
Table 24 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2001-2006
Table 25 Sales of Decongestants by Type: Value 2001-2006
Table 26 Sales of Decongestants by Type: % Value Growth 2001-2006
Table 27 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: Value 2001-2006
Table 28 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: % Value Growth 2001-2006
Table 29 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies 2001/2006
Table 30 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Retail Value 2002-2006
Table 31 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Retail Value 2003-2006
Table 32 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2006-2011
Table 33 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2006-2011
DIGESTIVE REMEDIES IN INDIA
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 34 Sales of Digestive Remedies by Subsector: Value 2001-2006
Table 35 Sales of Digestive Remedies by Subsector: % Value Growth 2001-2006
Table 36 Herbal vs Standard Digestive Remedies 2001/2006
Table 37 Digestive Remedies Company Shares by Retail Value 2002-2006
Table 38 Digestive Remedies Brand Shares by Retail Value 2003-2006
Table 39 Forecast Sales of Digestive Remedies by Subsector: Value 2006-2011
Table 40 Forecast Sales of Digestive Remedies by Subsector: % Value Growth 2006-2011
MEDICATED SKIN CARE IN INDIA
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 41 Sales of Medicated Skin Care by Subsector: Value 2001-2006
Table 42 Sales of Medicated Skin Care by Subsector: % Value Growth 2001-2006
Table 43 Herbal vs Standard Medicated Skin Care 2001/2006
Table 44 Medicated Skin Care Company Shares by Retail Value 2002-2006
Table 45 Medicated Skin Care Brand Shares by Retail Value 2003-2006
Table 46 Acne Treatments Brand Shares by Retail Value 2003-2006
Table 47 Forecast Sales of Medicated Skin Care by Subsector: Value 2006-2011
Table 48 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2006-2011
VITAMINS AND DIETARY SUPPLEMENTS IN INDIA
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 49 Sales of Vitamins and Dietary Supplements by Subsector: Value 2001-2006
Table 50 Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2001-2006
Table 51 Sales of Vitamins by Type: Value 2001-2006
Table 52 Sales of Vitamins by Type: % Value Growth 2001-2006
Table 53 Vitamins and Dietary Supplements Company Shares by Retail Value 2002-2006
Table 54 Vitamins and Dietary Supplements Brand Shares by Retail Value 2003-2006
Table 55 Vitamins Brand Shares by Retail Value 2003-2006
Table 56 Sales of Dietary Supplements by Type: Value 2001-2006
Table 57 Sales of Dietary Supplements by Type: % Value Growth 2001-2006
Table 58 Dietary Supplements Brand Shares by Retail Value 2003-2006
Table 59 Forecast Sales of Vitamins and Dietary Supplements by Subsector: Value 2006-2011
Table 60 Forecast Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2006-2011
NRT SMOKING CESSATION AIDS IN INDIA
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR INDICATORS
Table 61 Number of Smokers by Gender 2001-2006
EYE CARE IN INDIA
TRENDS
SECTOR DATA
Table 62 Sales of Eye Care by Subsector: Value 2001-2006
Table 63 Sales of Eye Care by Subsector: % Value Growth 2001-2006
Table 64 Eye Care Company Shares by Retail Value 2002-2006
Table 65 Eye Care Brand Shares by Retail Value 2003-2006
Table 66 Forecast Sales of Eye Care by Subsector: Value 2006-2011
Table 67 Forecast Sales of Eye Care by Subsector: % Value Growth 2006-2011
EAR CARE IN INDIA
TRENDS
ADULT MOUTHCARE IN INDIA
TRENDS
CALMING AND SLEEPING PRODUCTS IN INDIA
TRENDS
WOUND TREATMENTS IN INDIA
TRENDS
SECTOR DATA
Table 68 Sales of Wound Treatments by Subsector: Value 2001-2006
Table 69 Sales of Wound Treatments by Subsector: % Value Growth 2001-2006
Table 70 Wound Treatments Company Shares by Retail Value 2002-2006
Table 71 Wound Treatments Brand Shares by Retail Value 2003-2006
Table 72 Forecast Sales of Wound Treatments by Subsector: Value 2006-2011
Table 73 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2006-2011